Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone

Key facts

Sponsor

Changye Zou

Principal Investigator

Changye Zou, MD

First Affiliated Hospital, Sun Yat-Sen University

Intervention

gene expression levels(genetic)

Enrollment

145 target

Eligibility

All sexes

Timeline

2012 – 2023

Study locations (1)

• Churong Yan, Guangzhou, Guangdong, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Giant cell tumor of bone

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE4NCT07315828
  Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
  Shanghai Jiao Tong University Affiliated Sixth People's Hospital
• RECRUITINGNCT07227961
  PROMIS and Mobility Evaluation in Sarcoma Patients
  University of Calgary
• RECRUITINGPHASE1, PHASE2NCT06647901
  Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
  Tang Xiaodong
• ACTIVE NOT RECRUITINGPHASE4NCT04586660
  Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
  Amgen
• RECRUITINGPHASE2NCT05595603
  Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
  Second Affiliated Hospital, School of Medicine, Zhejiang University
• RECRUITINGPHASE3NCT03295981
  Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
  St. Louis University

See all trials for Giant cell tumor of bone →